Showing results (141-150 of 177) with videos related to

Sort By:
Pageof 18
International Journal of Urology : Official Journal of the Japanese Urological Association|January 26, 2022
Efficacy of combined androgen blockade therapy in patients with metastatic hormone-sensitive prostate cancer stratified by tumor burdenYoshiyuki Nagumo, Mizuki Onozawa, Takahiro Kojima, et al.
International Journal of Clinical Oncology|December 6, 2022
Clinical outcomes of intraductal carcinoma or cribriform in radical prostatectomy specimens of men opting for active surveillance: data from the PRIAS-JAPAN studyYoichiro Tohi, Ryou Ishikawa, Takuma Kato, et al.
Prostate Cancer and Prostatic Diseases|July 13, 2021
Reclassification prediction of first-year protocol biopsy on active surveillance of prostate cancer by p2PSA-related parameters: from PRIAS-JAPANTakuma Kato, Hiromi Hirama, Koji Mitsuzuka, et al.
International Journal of Urology : Official Journal of the Japanese Urological Association|July 21, 2026
Consensus-Based Development of a Surgical Checklist for Transurethral Resection of Bladder Tumor: An Initiative of the Japanese Society of Urologic OncologyRikiya Taoka, Nozomi Hayakawa, Tomokazu Kimura, et al.
International Journal of Urology : Official Journal of the Japanese Urological Association|May 25, 2022
Cancer-specific and net overall survival in older patients with de novo metastatic prostate cancer initially treated with androgen deprivation therapyShintaro Narita, Naoki Terada, Kyoko Nomura, et al.
Japanese Journal of Clinical Oncology|June 27, 2025
Temporal changes in the urologist's practice behaviour of active surveillance for prostate cancer: analysis of prospective observational study cohortYoichiro Tohi, Akira Yokomizo, Ryuji Matsumoto, et al.
BJU International|June 18, 2024
Outcomes of active surveillance for Japanese patients with prostate cancer (PRIAS-JAPAN)Takuma Kato, Ryuji Matsumoto, Akira Yokomizo, et al.
International Journal of Urology : Official Journal of the Japanese Urological Association|April 8, 2025
Active Surveillance in Prostate Cancer With Intermediate-Risk Features: The PRIAS-JAPAN StudyLeandro Blas, Masaki Shiota, Takuma Kato, et al.
Pageof 18